Myopia: Ocular and Systemic Disease

  • Quan V. Hoang
  • Jamie A. Leong
  • Roberto Gallego-Pinazo
Chapter

Abstract

The study of high axial myopia in the setting of antecedent, concurrent, or subsequent ocular disorders, systemic diseases, hereditary syndromes, and systemic drug use may contribute to our understanding of the pathogenesis of myopia and even set the occasion for the development of treatment. Although early recognition of mild myopic changes that commonly arise with certain ocular and systemic factors may limit the burden of vision loss with simple refractive correction, the recognition of high and pathologic axial myopia is important since there is a risk of permanent vision loss from vision-threatening sequelae. Therefore, the study of cases of high axial myopia, and specifically those cases in which there may be a causal relationship, is of particular interest. Additionally, recognition of the tendency of some syndromes to be associated with high myopia heightens the clinical suspicion for detection of severe refractive errors in patients who may be preverbal or unable to effectively communicate. Clinical studies and basic scientific discoveries oftentimes mirror and motivate each other. In this chapter, we detail clinical observations and studies that have proven or may in the future prove themselves relevant to current thoughts on emmetropization and animal models of myopia discussed more thoroughly elsewhere in this book.

Keywords

Retina Cataract Homocysteine Hemangioma Hydrochlorothiazide 

References

  1. 1.
    Wiesel TE, Raviola E. Myopia and eye enlargement after neonatal lid fusion in monkeys. Nature. 1977;266:66–8.PubMedGoogle Scholar
  2. 2.
    Sherman SM, Norton TT, Casagrande VA. Myopia in the lid sutured tree shrew (Tupaia glis). Brain Res. 1977;124:154–7.PubMedGoogle Scholar
  3. 3.
    Kirby AW, Sutton L, Weiss AH. Elongation of cat eyes following neonatal lid suture. Invest Ophthalmol Vis Sci. 1982;22:274–7.PubMedGoogle Scholar
  4. 4.
    Raviola E, Wiesel TN. An animal model of myopia. N Engl J Med. 1985;312:1609–16.PubMedGoogle Scholar
  5. 5.
    Lauber JK, Oishi T. Lid suture myopia in chicks. Invest Ophthalmol Vis Sci. 1987;28:1851–8. Kaufman L Jr. Pediatric tumors of the eye and orbit. Pediatr Clin North Am. 2003;50(1):149–72.Google Scholar
  6. 6.
    Diether S, Schaeffel F. Local changes in eye growth induced by imposed local refractive error despite active accommodation. Vision Res. 1997;37(6):659–68.PubMedGoogle Scholar
  7. 7.
    McBrien NA, Cornell LM, Gentle A. Structural and ultrastructural changes to the sclera in a mammalian model of high myopia. Invest Ophthalmol Vis Sci. 2001;42(10):2179–87.PubMedGoogle Scholar
  8. 8.
    Avetisov ES, Savitskaya NF, Vinetskaya MI, Iomdina EN. A study of biochemical and biomechanical qualities of normal and myopic eye sclera in humans of different age groups. Metab Pediatr Syst Ophthalmol. 1983;7(4):183–8.PubMedGoogle Scholar
  9. 9.
    Wollensak G, Iomdina E. Crosslinking of scleral collagen in the rabbit using glyceraldehyde. J Cataract Refract Surg. 2008;34(4):651–6.PubMedGoogle Scholar
  10. 10.
    McBrien NA, Lawlor P, Gentle A. Scleral remodeling during the development of and recovery from axial myopia in the tree shrew. Invest Ophthalmol Vis Sci. 2000;41:3713–9.PubMedGoogle Scholar
  11. 11.
    Norton TT, Rada JA. Reduced extracellular matrix in mammalian sclera with induced myopia. Vision Res. 1995;35(9):1271–81. Robb RM. Refractive errors associated with hemangiomas of the eyelids and orbit in infancy. Am J Ophthalmol. 1977;83(1):52–8.Google Scholar
  12. 12.
    Weiss AH. Unilateral high myopia: optical components, associated factors, and visual outcomes. Br J Ophthalmol. 2003;87(8):1025–31.PubMedGoogle Scholar
  13. 13.
    Johnson CA, Post RB, Chalupa LM, Lee TJ. Monocular deprivation in humans: a study of identical twins. Invest Ophthalmol Vis Sci. 1982;23(1):135–8.PubMedGoogle Scholar
  14. 14.
    Wildsoet CF, Schmid KL. Optical correction of form deprivation myopia inhibits refractive recovery in chick eyes with intact or sectioned optic nerves. Vision Res. 2000;40(23):3273–82.PubMedGoogle Scholar
  15. 15.
    Hoyt CS, Stone RD, Fromer C, Billson FA. Monocular axial myopia associated with neonatal eyelid closure in human infants. Am J Ophthalmol. 1981;91(2):197–200.PubMedGoogle Scholar
  16. 16.
    von Noorden GK, Lewis RA. Ocular axial length in unilateral congenital cataracts and blepharoptosis. Invest Ophthalmol Vis Sci. 1987;28(4):750–2.Google Scholar
  17. 17.
    Castillo Jr BV, Kaufman L. Pediatric tumors of the eye and orbit. Pediatr Clin North Am. 2003;50(1):149–72.PubMedGoogle Scholar
  18. 18.
    Robb RM. Refractive errors associated with hemangiomas of the eyelids and orbit in infancy. Am J Ophthalmol. 1977;83(1):52–8.PubMedGoogle Scholar
  19. 19.
    Gee SS, Tabbara KF. Increase in ocular axial length in patients with corneal opacification. Ophthalmology. 1988;95(9):1276–8.PubMedGoogle Scholar
  20. 20.
    Mahler O, Hoffman P, Pollack A, Marcovich A. Increase in posterior segment depth in eyes with corneal opacities. Harefuah. 2006;145(3):202–4, 245.PubMedGoogle Scholar
  21. 21.
    Wiesel TN, Raviola E. Increase in axial length of the macaque monkey after corneal opacification. Invest Ophthalmol Vis Sci. 1979;18:1232–6.PubMedGoogle Scholar
  22. 22.
    Miller-Meeks MJ, Bennett SR, Keech RV, Blodi CF. Myopia induced by vitreous hemorrhage. Am J Ophthalmol. 1990;109(2):199–203.PubMedGoogle Scholar
  23. 23.
    Yesou C, Poletti J. Posterior scleral ectasis. Bull Soc Ophtalmol Fr. 1990;90(3):349–52.PubMedGoogle Scholar
  24. 24.
    Ernst BJ, Hsu HY. Keratoconus association with axial myopia: a prospective biometric study. Eye Contact Lens. 2011;37(1):2–5.PubMedGoogle Scholar
  25. 25.
    Tuft SJ, Fitzke FW, Buckley RJ. Myopia following penetrating keratoplasty for keratoconus. Br J Ophthalmol. 1992;76(11):642–5.PubMedGoogle Scholar
  26. 26.
    Touzeau O, Scheer S, Allouch C, Borderie V, Laroche L. The relationship between keratoconus and axial myopia. J Fr Ophtalmol. 2004;27(7):765–71.PubMedGoogle Scholar
  27. 27.
    Sohajda Z, Holló D, Berta A, Módis L. Microcornea associated with myopia. Graefes Arch Clin Exp Ophthalmol. 2006;244(9):1211–3.PubMedGoogle Scholar
  28. 28.
    Batra DV, Paul SD. Microcornea with myopia. Br J Ophthalmol. 1967;51(1):57–60.PubMedGoogle Scholar
  29. 29.
    Hewitt AW, Kearns LS, Jamieson RV, Williamson KA, van Heyningen V, Mackey DA. PAX6 mutations may be associated with high myopia. Ophthalmic Genet. 2007;28(3):179–82.PubMedGoogle Scholar
  30. 30.
    Valenzuela A, Cline RA. Ocular and nonocular findings in patients with aniridia. Can J Ophthalmol. 2004;39(6):632–8.PubMedGoogle Scholar
  31. 31.
    Zhong XW, Ge J, Deng WG, Chen XL, Huang J. Expression of pax-6 in rhesus monkey of optical defocus induced myopia and form deprivation myopia. Chin Med J (Engl). 2004;117(5):722–6.Google Scholar
  32. 32.
    Ashby RS, Megaw PL, Morgan IG. Changes in the expression of Pax6 RNA transcripts in the retina during periods of altered ocular growth in chickens. Exp Eye Res. 2009;89(3):392–7.PubMedGoogle Scholar
  33. 33.
    Price MJ, Judisch GF, Thompson HS. X-linked congenital stationary night blindness with myopia and nystagmus without clinical complaints of nyctalopia. J Pediatr Ophthalmol Strabismus. 1988;25(1):33–6.PubMedGoogle Scholar
  34. 34.
    Haim M, Fledelius HC, Skarsholm D. X-linked myopia in Danish family. Acta Ophthalmol (Copenh). 1988;66(4):450–6.Google Scholar
  35. 35.
    Schubert G, Bornschein H. Analysis of the human electroretinogram. Ophthalmologica. 1952;123(6):396–413.PubMedGoogle Scholar
  36. 36.
    Miyake Y, Yagasaki K, Horiguchi M, et al. Congenital stationary night blindness with negative electroretinogram: a new classification. Arch Ophthalmol. 1986;104(7):1013–20.PubMedGoogle Scholar
  37. 37.
    Mäntyjärvi M, Tuppurainen K. Progressive cone-rod dystrophy and high myopia in a Finnish family. Acta Ophthalmol. 1989;67(3):234–42.Google Scholar
  38. 38.
    François J, Verriest G, Matton-Van Leuven T, De Rouck A, Manavian D. Atypical achromatopia of sex-linked recessive inheritance. Am J Ophthalmol. 1966;61(5 Pt 2):1101–8.PubMedGoogle Scholar
  39. 39.
    Kaplan J, Bonneau D, Frézal J, Munnich A, Dufier JL. Clinical and genetic heterogeneity in retinitis pigmentosa. Hum Genet. 1990;85(6):635–42.PubMedGoogle Scholar
  40. 40.
    Bende P, Natarajan K, Marudhamuthu T, Madhavan J. Severity of familial isolated retinitis pigmentosa across different inheritance patterns among an Asian Indian cohort. J Pediatr Ophthalmol Strabismus. 2013;50(1):34–6.PubMedGoogle Scholar
  41. 41.
    Schwartz M, Haim M, Skarsholm D. X-linked myopia: Bornholm eye disease. Linkage to DNA markers on the distal part of Xq. Clin Genet. 1990;38(4):281–6.PubMedGoogle Scholar
  42. 42.
    Metlapally R, Michaelides M, Bulusu A, Li YJ, Schwartz M, Rosenberg T, Hunt DM, Moore AT, Züchner S, Rickman CB, Young TL. Evaluation of the X-linked high-grade myopia locus (MYP1) with cone dysfunction and color vision deficiencies. Invest Ophthalmol Vis Sci. 2009;50(4):1552–8.PubMedGoogle Scholar
  43. 43.
    Nissenkorn I, Yassur Y, Mashkowski D, Sherf I, Ben-Sira I. Myopia in premature babies with and without retinopathy of prematurity. Br J Ophthalmol. 1983;67(3):170–3.PubMedGoogle Scholar
  44. 44.
    Quinn GE, Dobson V, Davitt BV, Hardy RJ, Tung B, Pedroza C, Good WV, Early Treatment for Retinopathy of Prematurity Cooperative Group. Progression of myopia and high myopia in the early treatment for retinopathy of prematurity study: findings to 3 years of age. Ophthalmology. 2008;115(6):1058–1064.e1.PubMedGoogle Scholar
  45. 45.
    Quinn GE, Dobson V, Siatkowski R, Hardy RJ, Kivlin J, Palmer EA, Phelps DL, Repka MX, Summers CG, Tung B, Chan W, Cryotherapy for Retinopathy of Prematurity Cooperative Group. Does cryotherapy affect refractive error? Results from treated versus control eyes in the cryotherapy for retinopathy of prematurity trial. Ophthalmology. 2001;108(2):343–7.PubMedGoogle Scholar
  46. 46.
    Harder BC, Schlichtenbrede FC, von Baltz S, Jendritza W, Jendritza B, Jonas JB. Intravitreal bevacizumab for retinopathy of prematurity: refractive error results. Am J Ophthalmol. 2013;155(6):1119–1124.e1.PubMedGoogle Scholar
  47. 47.
    Nessler M, Puchala J, Kwiatkowski S, Kobylarz K, Mojsa I, Chrapusta-Klimeczek A. Multidisciplinary approach to the treatment of a patient with chondrodystrophic myotonia (Schwartz-Jampel vel Aberfeld syndrome): case report and literature review. Ann Plast Surg. 2011;67(3):315–9.PubMedGoogle Scholar
  48. 48.
    Duncan PA. The Achard syndrome. Birth Defects Orig Artic Ser. 1975;11(6):69–73.PubMedGoogle Scholar
  49. 49.
    Jones JL, Lane JE, Logan JJ, Vanegas ME. Beals-Hecht syndrome. South Med J. 2002;95(7):753–5.PubMedGoogle Scholar
  50. 50.
    Tunçbilek E, Alanay Y. Congenital contractural arachnodactyly (Beals syndrome). Orphanet J Rare Dis. 2006;1:20.PubMedCentralPubMedGoogle Scholar
  51. 51.
    Gallego-Pinazo R, López-Lizcano R, Millán JM, Arevalo JF, Mullor JL, Díaz-Llopis M. Beals-Hecht syndrome and choroidal neovascularization. Clin Ophthalmol. 2010;4:845–7.PubMedCentralPubMedGoogle Scholar
  52. 52.
    Izquierdo NJ, Maumenee IH, Traboulsi EI. Anterior segment malformations in 18q- (de Grouchy) syndrome. Ophthalmic Paediatr Genet. 1993;14(2):91–4.PubMedGoogle Scholar
  53. 53.
    Kivitie-Kallio S, Norio R. Cohen syndrome: essential features, natural history, and heterogeneity. Am J Med Genet. 2001;102(2):125–35.PubMedGoogle Scholar
  54. 54.
    Douzgou S, Petersen MB. Clinical variability of genetic isolates of Cohen syndrome. Clin Genet. 2011;79(6):501–6.PubMedGoogle Scholar
  55. 55.
    Mace JW, Sponaugle HD, Mitsunaga RY, Schanberger JE. Congenital hereditary nonprogressive external ophthalmoplegia. Am J Dis Child. 1971;122(3):261–3.PubMedGoogle Scholar
  56. 56.
    Houtman WA, van Weerden TW, Robinson PH, de Vries B, Hoogenraad TU. Hereditary congenital external ophthalmoplegia. Ophthalmologica. 1986;193(4):207–18.PubMedGoogle Scholar
  57. 57.
    Levin AV, Seidman DJ, Nelson LB, Jackson LG. Ophthalmologic findings in the Cornelia de Lange syndrome. J Pediatr Ophthalmol Strabismus. 1990;27(2):94–102.PubMedGoogle Scholar
  58. 58.
    Liu J, Baynam G. Cornelia de Lange syndrome. Adv Exp Med Biol. 2010;685:111–23.PubMedGoogle Scholar
  59. 59.
    Galanos J, Nicholls K, Grigg L, Kiers L, Crawford A, Becker G. Clinical features of Fabry’s disease in Australian patients. Intern Med J. 2002;32(12):575–84.PubMedGoogle Scholar
  60. 60.
    Orssaud C, Dufier J, Germain D. Ocular manifestations in Fabry disease: a survey of 32 hemizygous male patients. Ophthalmic Genet. 2003;24(3):129–39.PubMedGoogle Scholar
  61. 61.
    Nguyen TT, Gin T, Nicholls K, Low M, Galanos J, Crawford A. Ophthalmological manifestations of Fabry disease: a survey of patients at the Royal Melbourne Fabry Disease Treatment Centre. Clin Experiment Ophthalmol. 2005;33(2):164–8.PubMedGoogle Scholar
  62. 62.
    Strömland K, Pinazo-Durán MD. Ophthalmic involvement in the fetal alcohol syndrome: clinical and animal model studies. Alcohol Alcohol. 2002;37(1):2–8.PubMedGoogle Scholar
  63. 63.
    Hiratsuka Y, Li G. Alcohol and eye diseases: a review of epidemiologic studies. J Stud Alcohol. 2001;62(3):397–402.PubMedGoogle Scholar
  64. 64.
    O’Donnell FE, Green WR, McKusick VA, Forsius H, Eriksson AW. Forsius-Eriksson syndrome: its relation to the Nettleship-Falls X-linked ocular albinism. Clin Genet. 1980;17(6):403–8.PubMedGoogle Scholar
  65. 65.
    Gillum WN, Anderson RL. Dominantly inherited blepharoptosis, high myopia, and ectopia lentis. Arch Ophthalmol. 1982;100(2):282–4.PubMedGoogle Scholar
  66. 66.
    Haney WP, Falls HF. The occurrence of congenital keratoconus posticus circumscriptus in two siblings presenting a previously unrecognized syndrome. Am J Ophthalmol. 1961;52:53.PubMedGoogle Scholar
  67. 67.
    Gündüz K, Shields CL, Doych Y, Schnall B, Shields JA. Ocular ectodermal syndrome of epibulbar dermoid and cutaneous myxovascular hamartoma. Br J Ophthalmol. 2000;84(6):669–70.PubMedGoogle Scholar
  68. 68.
    Ekins MB, Waring III GO. Absent meibomian glands and reduced corneal sensation in hypohidrotic ectodermal dysplasia. J Pediatr Ophthalmol Strabismus. 1981;18:44–7.PubMedGoogle Scholar
  69. 69.
    Freire MN, et al. A syndrome of hypohidrotic ectodermal dysplasia with normal teeth, peculiar facies, pigmentary disturbances, psychomotor and growth retardation, bilateral nuclear cataract, and other signs. J Med Genet. 1975;12:308–10.Google Scholar
  70. 70.
    Mossberg R. Immotile-cilia syndrome: clinical features. Eur J Respir Dis Suppl. 1982;118:111–5.PubMedGoogle Scholar
  71. 71.
    Davenport JR, Yoder BK. An incredible decade for the primary cilium: a look at a once-forgotten organelle. Am J Physiol Renal Physiol. 2005;289(6):F1159–69.PubMedGoogle Scholar
  72. 72.
    Krawczyński MR, Dmeńska H, Witt M. Apparent X-linked primary ciliary dyskinesia associated with retinitis pigmentosa and a hearing loss. J Appl Genet. 2004;45(1):107–10.PubMedGoogle Scholar
  73. 73.
    Majewski F, Rosendahl W, Ranke M, Nolte K. The Kenny syndrome, a rare type of growth deficiency with tubular stenosis, transient hypoparathyroidism and anomalies of refraction. Eur J Pediatr. 1981;136(1):21–30.PubMedGoogle Scholar
  74. 74.
    Tsai CE, Chiu PC, Lee ML. Kenny syndrome: case report and literature review. J Formos Med Assoc. 1996;95(10):793–7.PubMedGoogle Scholar
  75. 75.
    Maumenee IH, Traboulsi EI. The ocular findings in Kniest dysplasia. Am J Ophthalmol. 1985;100(1):155–60.PubMedGoogle Scholar
  76. 76.
    Bardelli AM, Lasorella G, Barberi L, Vanni M. Ocular manifestations in Kniest syndrome, Smith-Lemli-Opitz syndrome, Hallermann-Streiff-François syndrome, Rubinstein-Taybi syndrome and median cleft face syndrome. Ophthalmic Paediatr Genet. 1985;6(1–2):343–7.PubMedGoogle Scholar
  77. 77.
    Héon E, Westall C, Carmi R, Elbedour K, Panton C, Mackeen L, Stone EM, Sheffield VC. Ocular phenotypes of three genetic variants of Bardet-Biedl syndrome. Am J Med Genet A. 2005;132A(3):283–7.PubMedGoogle Scholar
  78. 78.
    Abd-El-Barr MM, Sykoudis K, Andrabi S, Eichers ER, Pennesi ME, Tan PL, Wilson JH, Katsanis N, Lupski JR, Wu SM. Impaired photoreceptor protein transport and synaptic transmission in a mouse model of Bardet–Biedl syndrome. Vision Res. 2007;47(27):3394–407.PubMedCentralPubMedGoogle Scholar
  79. 79.
    Zaldivar RA, Neale MD, Evans WE, Pulido JS. Asymptomatic renal cell carcinoma as a finding of Bardet Biedl syndrome. Ophthalmic Genet. 2008;29(1):33–5.PubMedGoogle Scholar
  80. 80.
    Evereklioglu C, Hepsen IF, Er H. Weill-Marchesani syndrome in three generations. Eye (Lond). 1999;13(Pt 6):773–7.Google Scholar
  81. 81.
    Faivre L, Dollfus H, Lyonnet S, Alembik Y, Mégarbané A, Samples J, Gorlin RJ, Alswaid A, Feingold J, Le Merrer M, Munnich A, Cormier-Daire V. Clinical homogeneity and genetic heterogeneity in Weill-Marchesani syndrome. Am J Med Genet A. 2003;123A(2):204–7.PubMedGoogle Scholar
  82. 82.
    Shanske AL, Bogdanow A, Shprintzen RJ, Marion RW. The Marshall syndrome: report of a new family and review of the literature. Am J Med Genet. 1997;70(1):52–7.PubMedGoogle Scholar
  83. 83.
    Matsoukas J, Liarikos S, Giannikas A, Agoropoulos Z, Papachristou G, Soukakos P. A newly recognized dominantly inherited syndrome: short stature, ocular and articular anomalies, mental retardation. Helv Paediatr Acta. 1973;28(5):383–6.PubMedGoogle Scholar
  84. 84.
    Bocca G, de Vries J, Cruysberg JR, Boers GH, Monnens LA. Optic neuropathy in McCune-Albright syndrome: an indication for aggressive treatment. Acta Paediatr. 1998;87(5):599–600.PubMedGoogle Scholar
  85. 85.
    Niwald A, Budzińska-Mikurenda M, Rogozińska-Zawiślak A, Mikołajczyk W, Niwald M, Grałek M. Visual symptoms in McCune-Albright syndrome – case report. Klin Oczna. 2006;108(1–3):131–3.PubMedGoogle Scholar
  86. 86.
    Braun M, Seitz B, Naumann GO. Juvenile open angle glaucoma with microcornea in oculo-dento-digital dysplasia (Meyer-Schwickerath-Weyers syndrome). Klin Monbl Augenheilkd. 1996;208(4):262–3.PubMedGoogle Scholar
  87. 87.
    Reich H. Meyer-Schwickerath-Weyers syndrome (oculo-dento-digital syndrome). Hautarzt. 1980;31(9):515.PubMedGoogle Scholar
  88. 88.
    Tartaglia M, Mehler EL, Goldberg R, Zampino G, Brunner HG, Kremer H, van der Burgt I, Crosby AH, Ion A, Jeffery S, Kalidas K, Patton MA, Kucherlapati RS, Gelb BD. Mutations in PTPN11, encoding the protein tyrosine phosphatase SHP-2, cause Noonan syndrome. Nat Genet. 2001;29(4):465–8.PubMedGoogle Scholar
  89. 89.
    Tartaglia M, Gelb BD, Zenker M. Noonan syndrome and clinically related disorders. Best Pract Res Clin Endocrinol Metab. 2011;25(1):161–79.PubMedCentralPubMedGoogle Scholar
  90. 90.
    Marin Lda R, da Silva FT, de Sá LC, Brasil AS, Pereira A, Furquim IM, Kim CA, Bertola DR. Ocular manifestations of Noonan syndrome. Ophthalmic Genet. 2012;33(1):1–5.PubMedGoogle Scholar
  91. 91.
    Cohen Jr MM, Hall BD, Smith DW, Graham CB, Lampert KJ. A new syndrome with hypotonia, obesity, mental deficiency, and facial, oral, ocular, and limb anomalies. J Pediatr. 1973;83(2):280–4.7.PubMedGoogle Scholar
  92. 92.
    Huang F, Kuo HK, Hsieh CH, Lai JP, Chen PK. Visual complications of Stickler syndrome in paediatric patients with Robin sequence. J Craniomaxillofac Surg. 2007;35(2):76–80.PubMedGoogle Scholar
  93. 93.
    Witmer MT, Vasan R, Levy R, Davis J, Chan RV. Bilateral maculopathy associated with Pierre Robin sequence. J AAPOS. 2012;16(4):409–10.PubMedGoogle Scholar
  94. 94.
    Hered RW, Rogers S, Zang YF, Biglan AW. Ophthalmologic features of Prader-Willi syndrome. J Pediatr Ophthalmol Strabismus. 1988;25(3):145–50.PubMedGoogle Scholar
  95. 95.
    Wang XC, Norose K, Kiyosawa K, Segawa K. Ocular findings in a patient with Prader-Willi syndrome. Jpn J Ophthalmol. 1995;39(3):284–9.PubMedGoogle Scholar
  96. 96.
    Josaitis CA, Matisoff M. Familial dysautonomia in review: diagnosis and treatment of ocular manifestations. Adv Exp Med Biol. 2002;506(Pt A):71–80.PubMedGoogle Scholar
  97. 97.
    Mendoza-Santiesteban CE, Hedges 3rd TR, Norcliffe-Kaufmann L, Warren F, Reddy S, Axelrod FB, Kaufmann H. Clinical neuro-ophthalmic findings in familial dysautonomia. J Neuroophthalmol. 2012;32(1):23–6.PubMedGoogle Scholar
  98. 98.
    van Genderen MM, Kinds GF, Riemslag FC, Hennekam RC. Ocular features in Rubinstein-Taybi syndrome: investigation of 24 patients and review of the literature. Br J Ophthalmol. 2000;84(10):1177–84.PubMedGoogle Scholar
  99. 99.
    Kumar S, Suthar R, Panigrahi I, Marwaha RK. Rubinstein-Taybi syndrome: clinical profile of 11 patients and review of literature. Indian J Hum Genet. 2012;18(2):161–6.PubMedCentralPubMedGoogle Scholar
  100. 100.
    Mallineni SK, Yiu CK, King NM. Schwartz-Jampel syndrome: a review of the literature and case report. Spec Care Dentist. 2012;32(3):105–11.PubMedGoogle Scholar
  101. 101.
    Arya R, Sharma S, Gupta N, Kumar S, Kabra M, Gulati S. Schwartz Jampel syndrome in children. J Clin Neurosci. 2013;20(2):313–7.PubMedGoogle Scholar
  102. 102.
    Tuomaala P, Haapanen E. Three siblings with similar anomalies in the eyes, bones and skin. Acta Ophthalmol (Copenh). 1968;46(3):365–71.Google Scholar
  103. 103.
    Durner W. Van Bogaert-Hozay-syndrome. A case demonstration. Klin Monbl Augenheilkd. 1973;162(5):658–60.PubMedGoogle Scholar
  104. 104.
    Zlotgora J. Wrinkly skin syndrome and the syndrome of cutis laxa with growth and developmental delay represent the same disorder. Am J Med Genet. 1999;85(2):194.Google Scholar
  105. 105.
    Hamamy H, Masri A, Ajlouni K. Wrinkly skin syndrome. Clin Exp Dermatol. 2005;30(5):590–2.PubMedGoogle Scholar
  106. 106.
    Dietz HC, Saraiva JM, Pyeritz RE, Cutting GR, Francomano CA. Clustering of fibrillin (FBN1) missense mutations in Marfan syndrome patients at cysteine residues in EGF-like domains. Hum Mutat. 1992;1(5):366–74.PubMedGoogle Scholar
  107. 107.
    Nahum Y, Spierer A. Ocular features of Marfan syndrome: diagnosis and management. Isr Med Assoc J. 2008;10(3):179–81.PubMedGoogle Scholar
  108. 108.
    De Paepe A, Malfait F. The Ehlers-Danlos syndrome, a disorder with many faces. Clin Genet. 2012;82(1):1–11.PubMedGoogle Scholar
  109. 109.
    Pemberton JW, Freeman HM, Schepens CL. Familial retinal detachment and the Ehlers-Danlos syndrome. Arch Ophthalmol. 1966;76(6):817–24.PubMedGoogle Scholar
  110. 110.
    Snead MP, Yates JR. Clinical and Molecular genetics of Stickler syndrome. J Med Genet. 1999;36(5):353–9.PubMedGoogle Scholar
  111. 111.
    Snead MP, McNinch AM, Poulson AV, Bearcroft P, Silverman B, Gomersall P, Parfect V, Richards AJ. Stickler syndrome, ocular-only variants and a key diagnostic role for the ophthalmologist. Eye (Lond). 2011;25(11):1389–400.Google Scholar
  112. 112.
    Godel V, Nemet P, Lazar M. The Wagner-Stickler syndrome complex. Doc Ophthalmol. 1981;52(2):179–88.PubMedGoogle Scholar
  113. 113.
    Van der Hoeve J, de Kleyn A. Blaue Scleren, Knochenbrüchigkeit und Schwerhörigkeit. Arch Ophthalmol. 1918;95:81–93.Google Scholar
  114. 114.
    Alikadić-Husović A, Merhemić Z. The blue sclera syndrome (Van der Heave syndrome). Med Arh. 2000;54(5–6):325–6.PubMedGoogle Scholar
  115. 115.
    Fedelius H, Zak M, Pedersen FK. Refraction in juvenile chronic arthritis: a long-term follow-up study, with emphasis on myopia. Acta Ophthalmol Scand. 2001;79:237–9.Google Scholar
  116. 116.
    Herbort CP, Papadia M, Neri P. Myopia and inflammation. J Ophthalmic Vis Res. 2011;6(4):270–83.PubMedCentralPubMedGoogle Scholar
  117. 117.
    Alexander LJ. The tilted disc syndrome. J Am Optom Assoc. 1978;49(9):1060–2.PubMedGoogle Scholar
  118. 118.
    Sowka J, Aoun P. Tilted disc syndrome. Optom Vis Sci. 1999;76(9):618–23.PubMedGoogle Scholar
  119. 119.
    Manor RS. Temporal field defects due to nasal tilting of discs. Ophthalmologica. 1974;168(4):269–81.PubMedGoogle Scholar
  120. 120.
    Bangal S, Bhandari A, Dhaytadak P, Gogri P. Gyrate atrophy of choroid and retina with myopia, cataract and systemic proximal myopathy: a rare case report from rural India. Australas Med J. 2012;5(12):639–42.PubMedCentralPubMedGoogle Scholar
  121. 121.
    Shenoi A, Nirmala L, Christopher R. Hyperornithinemia associated with gyrate atrophy of the choroid and retina in a child with myopia. Indian Pediatr. 2001;38(8):914–8.PubMedGoogle Scholar
  122. 122.
    Valle D, Kaiser-Kupfer M. Gyrate atrophy of the choroid and retina. Prog Clin Biol Res. 1982;82:123–34.PubMedGoogle Scholar
  123. 123.
    Sergouniotis PI, Davidson AE, Lenassi E, Devery SR, Moore AT, Webster AR. Retinal structure, function, and molecular pathologic features in gyrate atrophy. Ophthalmology. 2012;119(3):596–605.PubMedGoogle Scholar
  124. 124.
    Renner AB, Walter A, Fiebig BS, Jägle H. Gyrate atrophy: clinical and genetic findings in a female without arginine-restricted diet during her first 39 years of life and report of a new OAT gene mutation. Doc Ophthalmol. 2012;125(1):81–9.PubMedGoogle Scholar
  125. 125.
    François J. Ocular manifestations in aminoacidopathies. Adv Ophthalmol. 1972;25:28–103.PubMedGoogle Scholar
  126. 126.
    Zaidi SH, Faiyaz-Ul-Haque M, Shuaib T, Balobaid A, Rahbeeni Z, Abalkhail H, Al-Abdullatif A, Al-Hassnan Z, Peltekova I, Al-Owain M. Clinical and molecular findings of 13 families from Saudi Arabia and a family from Sudan with homocystinuria. Clin Genet. 2012;81(6):563–70.PubMedGoogle Scholar
  127. 127.
    Scherbenske JM, Benson PM, Rotchford JP, James WD. Cutaneous and ocular manifestations of Down syndrome. J Am Acad Dermatol. 1990;22(5 Pt 2):933–8.PubMedGoogle Scholar
  128. 128.
    Creavin AL, Brown RD. Ophthalmic abnormalities in children with Down syndrome. J Pediatr Ophthalmol Strabismus. 2009;46(2):76–82.PubMedGoogle Scholar
  129. 129.
    Ljubic A, Trajkovski V. Refractive errors in children and young adults with Down’s syndrome. Acta Ophthalmol. 2011;89(4):324–7.PubMedGoogle Scholar
  130. 130.
    Stirn Kranjc B. Ocular abnormalities and systemic disease in Down syndrome. Strabismus. 2012;20(2):74–7.PubMedGoogle Scholar
  131. 131.
    Jiang L, Long K, Schaeffel F, Zhang S, Zhou X, Lu F, Qu J. Disruption of emmetropization and high susceptibility to deprivation myopia in albino guinea pigs. Invest Ophthalmol Vis Sci. 2011;52(9):6124–32.PubMedGoogle Scholar
  132. 132.
    Rymer J, Choh V, Bharadwaj S, Padmanabhan V, Modilevsky L, Jovanovich E, Yeh B, Zhang Z, Guan H, Payne W, Wildsoet CF. The albino chick as a model for studying ocular developmental abnormalities, including refractive errors, associated with albinism. Exp Eye Res. 2007;85(4):431–42.PubMedCentralPubMedGoogle Scholar
  133. 133.
    Fonda G, Thomas H, Gore 3rd GV. Educational and vocational placement, and low-vision corrections in albinism. A report bases on 235 patients. Sight Sav Rev. 1971;41(7):29–36.PubMedGoogle Scholar
  134. 134.
    Krieg PH, Schipper I. Drug-induced ciliary body oedema: a new theory. Eye (Lond). 1996;10(Pt 1):121–6.Google Scholar
  135. 135.
    Ryan Jr EH, Jampol LM. Drug-induced acute transient myopia with retinal folds. Retina. 1986;6(4):220–3.PubMedGoogle Scholar
  136. 136.
    Fan JT, Johnson DH, Burk RR. Transient myopia, angle-closure glaucoma, and choroidal detachment after oral acetazolamide. Am J Ophthalmol. 1993;115(6):813–4.PubMedGoogle Scholar
  137. 137.
    Fraunfelder FW, Fraunfelder FT, Keates EU. Topiramate-associated acute, bilateral, secondary angle-closure glaucoma. Ophthalmology. 2004;111(1):109–11.PubMedGoogle Scholar
  138. 138.
    Fraunfelder FT, Fraunfelder FW. Drug-induced ocular side effects. 5th ed. Boston: Butterworth-Heinemann; 2001.Google Scholar
  139. 139.
    Bovino JA, Marcus DF. The mechanism of transient myopia induced by sulfonamide therapy. Am J Ophthalmol. 1982;94(1):99–102.PubMedGoogle Scholar
  140. 140.
    Hook SR, Holladay JT, Prager TC, Goosey JD. Transient myopia induced by sulfonamides. Am J Ophthalmol. 1986;101(4):495–6.PubMedGoogle Scholar
  141. 141.
    Chirls IA, Norris JW. Transient myopia associated with vaginal sulfanilamide suppositories. Am J Ophthalmol. 1984;98(1):120–1.PubMedGoogle Scholar
  142. 142.
    Milea D, Zech C, Dumontet C, Coiffier B, Trepsat C. Transient acute myopia induced by antilymphocyte globulins. Ophthalmologica. 1999;213(2):133–4.PubMedGoogle Scholar
  143. 143.
    Ramos-Esteban JC, Goldberg S, Danias J. Drug induced acute myopia with supraciliary choroidal effusion in a patient with Wegener’s granulomatosis. Br J Ophthalmol. 2002;86(5):594–6.PubMedGoogle Scholar
  144. 144.
    Kimura R, Kasai M, Shoji K, Kanno C. Swollen ciliary processes as an initial symptom in Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol. 1983;95(3):402–3.PubMedGoogle Scholar
  145. 145.
    Drug-induced myopia. Rev Prescr. 2002;22(226):200–2.Google Scholar
  146. 146.
    Maddalena MA. Transient myopia associated with acute glaucoma and retinal edema following vaginal administration of sulfanilamide. Arch Ophthalmol. 1968;80(2):186–8.PubMedGoogle Scholar
  147. 147.
    Grinbaum A, Ashkenazi I, Gutman I, Blumenthal M. Suggested mechanism for acute transient myopia after sulfonamide treatment. Ann Ophthalmol. 1993;25(6):224–6.PubMedGoogle Scholar
  148. 148.
    Bard LA. Transient myopia associated with promethazine (phenergan) therapy: report of a case. Am J Ophthalmol. 1964;58:682–6.PubMedGoogle Scholar
  149. 149.
    Ericson LA. Hygroton-induced myopia and retinal edema. Acta Ophthalmol (Copenh). 1963;41:538–43.Google Scholar
  150. 150.
    Söylev MF, Green RL, Feldon SE. Choroidal effusion as a mechanism for transient myopia induced by hydrochlorothiazide and triamterene. Am J Ophthalmol. 1995;120(3):395–7.PubMedGoogle Scholar
  151. 151.
    Banta JT, Hoffman K, Budenz DL, Ceballos E, Greenfield DS. Presumed topiramate-induced bilateral acute angle-closure glaucoma. Am J Ophthalmol. 2001;132(1):112–4.PubMedGoogle Scholar
  152. 152.
    Craig JE, Ong TJ, Louis DL, Wells JM. Mechanism of topiramate-induced acute-onset myopia and angle closure glaucoma. Am J Ophthalmol. 2004;137(1):193–5.PubMedGoogle Scholar
  153. 153.
    Jampolsky A, Flom B. Transient myopia associated with anterior displacement of the crystalline lens. Am J Ophthalmol. 1953;36(1):81–5.PubMedGoogle Scholar
  154. 154.
    Alvaro ME. Effects other than anti-infectious of sulfonamide compounds on the eye. Arch Ophthalmol. 1960;63:315–18.Google Scholar
  155. 155.
    Harrison RJ. Ocular adverse reactions to systemic drug therapy. Adverse Drug React Bull. 1996;180:683–6.Google Scholar
  156. 156.
    Mattsson R. Transient myopia following the use of sulphonamides. Acta Ophthalmol (Copenh). 1952;30(4):385–98.Google Scholar
  157. 157.
    Muirhead JF, Scheie HG. Transient myopia after acetazolamide. Arch Ophthalmol. 1960;63:315–8.PubMedGoogle Scholar
  158. 158.
    Beasley FJ. Transient myopia and retinal edema during ethoxzolamide (cardrase) therapy. Arch Ophthalmol. 1962;68:490–1.PubMedGoogle Scholar
  159. 159.
    Beasley FJ. Transient myopia and retinal edema during hydrochlorothiazide (hydrodiuril) therapy. Arch Ophthalmol. 1961;65:212–3.PubMedGoogle Scholar
  160. 160.
    Michaelson JJ. Transient myopia due to hygroton. Am J Ophthalmol. 1962;54:1146–7.PubMedGoogle Scholar
  161. 161.
    Yasuna E. Acute myopia associated with prochlorperazine (compazine) therapy. Am J Ophthalmol. 1962;54:793–6.PubMedGoogle Scholar
  162. 162.
    Galin MA, Baras I, Zweifach P. Diamox-induced myopia. Am J Ophthalmol. 1962;54:237–40.PubMedGoogle Scholar
  163. 163.
    Garland MA, Sholk A, Guenter KE. Acetazolamide-induced myopia. Am J Obstet Gynecol. 1962;84:69–71.PubMedGoogle Scholar
  164. 164.
    Grossman EE, Hanley W. Transient myopia during treatment for hypertension with autonomic blocking agents. Arch Ophthalmol. 1960;63:853–5.PubMedGoogle Scholar
  165. 165.
    Stratos AA, Peponis VG, Portaliou DM, Stroubini TE, Skouriotis S, Kymionis GD. Secondary pseudomyopia induced by amisulpride. Optom Vis Sci. 2011;88(11):1380–2.PubMedGoogle Scholar
  166. 166.
    Sandford-Smith JH. Transient myopia after aspirin. Br J Ophthalmol. 1974;58(7):698–700.PubMedGoogle Scholar
  167. 167.
    Korol’ EA. Transitory myopia in combination with transitory glaucoma. Zdravookhr Beloruss. 1962;8:66–7. Russian.PubMedGoogle Scholar
  168. 168.
    Postel EA, Assalian A, Epstein DL. Drug-induced transient myopia and angle-closure glaucoma associated with supraciliary choroidal effusion. Am J Ophthalmol. 1996;122(1):110–2.PubMedGoogle Scholar
  169. 169.
    Gilmartin B, Winfield NR. The effect of topical beta-adrenoceptor antagonists on accommodation in emmetropia and myopia. Vision Res. 1995;35(9):1305–12.PubMedGoogle Scholar
  170. 170.
    Manor RS, Dickerman Z, Llaron Z. Myopia during bromocriptine treatment. Lancet. 1981;1(8211):102.PubMedGoogle Scholar
  171. 171.
    Pallin O, Ericsson R. Ultrasound studies in a case of hygroton-induced myopia. Acta Ophthalmol (Copenh). 1965;43(5):692–6.Google Scholar
  172. 172.
    Mahesh G, Giridhar A, Saikumar SJ, Fegde S. Drug-induced acute myopia following chlorthalidone treatment. Indian J Ophthalmol. 2007;55(5):386–8.PubMedCentralPubMedGoogle Scholar
  173. 173.
    Stern JJ. Transient myopia in case of dermatitis treated with corticotropin. AMA Arch Ophthalmol. 1955;54(5):762.PubMedGoogle Scholar
  174. 174.
    Arranz JA, Jiménez R, Alvarez-Mon M. Cyclophosphamide-induced myopia. Ann Intern Med. 1992;116(1):92–3.PubMedGoogle Scholar
  175. 175.
    Flecinide orale LP-Flecaine LP. L’evaluation n’a pas progresse. Rev Prescr. 2006;26(269):96.Google Scholar
  176. 176.
    Teller J, Rasin M, Abraham FA. Accommodation insufficiency induced by glybenclamide. Ann Ophthalmol. 1989;21(7):275–6.PubMedGoogle Scholar
  177. 177.
    Roh YR, Woo SJ, Park KH. Acute-onset bilateral myopia and ciliochoroidal effusion induced by hydrochlorothiazide. Korean J Ophthalmol. 2011;25(3):214–7.PubMedCentralPubMedGoogle Scholar
  178. 178.
    Blain P, Paques M, Massin P, Erginay A, Santiago P, Gaudric A. Acute transient myopia induced by indapamide. Am J Ophthalmol. 2000;129(4):538–40.PubMedGoogle Scholar
  179. 179.
    Dangel ME, Weber PA, Leier CB. Transient myopia following isosorbide dinitrate. Ann Ophthalmol. 1983;15(12):1156–8.PubMedGoogle Scholar
  180. 180.
    Fraunfelder FT, Fraunfelder FW, Edwards R. Ocular side effects possibly associated with isotretinoin usage. Am J Ophthalmol. 2001;132(3):299–305.PubMedGoogle Scholar
  181. 181.
    Palestine AG. Transient acute myopia resulting from isotretinoin (accutane) therapy. Ann Ophthalmol. 1984;16(7):660, 662.PubMedGoogle Scholar
  182. 182.
    Kashani S, Barclay D, Lee E, Hollick E. A case of transient myopia in a patient with multiple myeloma secondary to levomepromazine. Palliat Med. 2005;19(3):261–2.PubMedGoogle Scholar
  183. 183.
    Vishwakarma P, Raman GV, Sathyan P. Mefenamic acid-induced bilateral transient myopia, secondary angle closure glaucoma and choroidal detachment. Indian J Ophthalmol. 2009;57(5):398–400.PubMedCentralPubMedGoogle Scholar
  184. 184.
    Kwon SJ, Park DH, Shin JP. Bilateral transient myopia, angle-closure glaucoma, and choroidal detachment induced by methazolamide. Jpn J Ophthalmol. 2012;56(5):515–7.PubMedGoogle Scholar
  185. 185.
    Grinbaum A, Ashkenazi I, Avni I, Blumenthal M. Transient myopia following metronidazole treatment for Trichomonas vaginalis. JAMA. 1992;267(4):511–2.PubMedGoogle Scholar
  186. 186.
    Doman DB, Baum MD. Olsalazine sodium can cause myopia that can be clinically confused with the uveitis of inflammatory bowel disease. Am J Gastroenterol. 1992;87(11):1684–5.PubMedGoogle Scholar
  187. 187.
    Zeyneloglu P, Karaaslan P, Kizilkan A, Durmaz L, Arslan G. An unusual adverse effect of an accidental epidural morphine overdose. Eur J Anaesthesiol. 2006;23(12):1061–2.PubMedGoogle Scholar
  188. 188.
    Corcelle L. The eye and oral contraceptives. Annee Ther Clin Ophtalmol. 1971;22:157–63. French.PubMedGoogle Scholar
  189. 189.
    Michiels J, Laterre C, Dumoulin D. Ocular manifestations of Wilson’s disease treated by penicillamine. Bull Soc Belge Ophtalmol. 1963;132:552–61. French.PubMedGoogle Scholar
  190. 190.
    Johnston L. Ocular toxicity-of systemic drugs. On Contin Pract. 1988;15(3):2–6.Google Scholar
  191. 191.
    Rengstorff RH. Myopia induced by ocular instillation of physostigmine. Am J Optom Arch Am Acad Optom. 1970;47(3):221–7.PubMedGoogle Scholar
  192. 192.
    Segal A, Aisemberg A, Ducasse A. Quinine, transient myopia and angle-closure glaucoma. Bull Soc Ophtalmol Fr. 1983;83(2):247–9. French.PubMedGoogle Scholar
  193. 193.
    Belci C. Transitory myopia in the course of therapy with diuretics. Boll Ocul. 1968;47(1):24–31. Italian.PubMedGoogle Scholar
  194. 194.
    Hilton EJ, Hosking SL, Betts T. The effect of antiepileptic drugs on visual performance. Seizure. 2004;13(2):113–28. Review.PubMedGoogle Scholar
  195. 195.
    Santodomingo-Rubido J, Gilmartin B, Wolffsohn JS. Drug-induced bilateral transient myopia with the sulphonamide sulphasalazine. Ophthalmic Physiol Opt. 2003;23(6):567–70.PubMedGoogle Scholar
  196. 196.
    Panday VA, Rhee DJ. Review of sulfonamide-induced acute myopia and acute bilateral angle-closure glaucoma. Compr Ophthalmol Update. 2007;8(5):271–6. Review.PubMedGoogle Scholar
  197. 197.
    Edwards TS. Transient myopia due to tetracycline. JAMA. 1963;186:69–70.PubMedGoogle Scholar
  198. 198.
    Worthen DM. Patient compliance and the “usefulness product” of timolol. Surv Ophthalmol. 1979;23(6):403–6.PubMedGoogle Scholar
  199. 199.
    Dorronzoro E, Santos-Bueso E, Vico-Ruiz E, Sáenz-Frances F, Argaya J, Gegúndez-Fernández JA. Myopia and retinal striae induced by topiramate. Arch Soc Esp Oftalmol. 2011;86(1):24–6.PubMedGoogle Scholar
  200. 200.
    Gualtieri W, Janula J. Topiramate maculopathy. Int Ophthalmol. 2013;33(1):103–6.PubMedGoogle Scholar
  201. 201.
    Ikeda N, Ikeda T, Nagata M, Mimura O. Ciliochoroidal effusion syndrome induced by sulfa derivatives. Arch Ophthalmol. 2002;120(12):1775.PubMedGoogle Scholar
  202. 202.
    Rhee DJ, Goldberg MJ, Parrish RK. Bilateral angle-closure glaucoma and ciliary body swelling from topiramate. Arch Ophthalmol. 2001;119(11):1721–3.PubMedGoogle Scholar
  203. 203.
    Sen HA, O’Halloran HS, Lee WB. Case reports and small case series: topiramate-induced acute myopia and retinal striae. Arch Ophthalmol. 2001;119(5):775–7.PubMedGoogle Scholar
  204. 204.
    Kirchner KA, Martin CJ, Bower JD. Prostaglandin E2 but not I2 restores furosemide response in indomethacin-treated rats. Am J Physiol. 1986;250(6 Pt 2):F980–5.PubMedGoogle Scholar
  205. 205.
    Fraunfelder FW, Solomon J, Mehelas TJ. Ocular adverse effects associated with cyclooxygenase-2 inhibitors. Arch Ophthalmol. 2006;124(2):277–9.PubMedGoogle Scholar
  206. 206.
    Lee GC, Tam CP, Danesh-Meyer HV, Myers JS, Katz LJ. Bilateral angle closure glaucoma induced by sulphonamide-derived medications. Clin Experiment Ophthalmol. 2007;35(1):55–8.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Quan V. Hoang
    • 1
    • 2
    • 3
  • Jamie A. Leong
    • 1
  • Roberto Gallego-Pinazo
    • 2
    • 3
    • 4
  1. 1.Department of OphthalmologyEdward S. Harkness Eye Institute, Columbia University Medical CenterNew YorkUSA
  2. 2.Vitreous Retina Macula Consultants of New YorkNew YorkUSA
  3. 3.LuEsther T. Mertz Retinal Research Center, Manhattan Eye, Ear, and Throat HospitalNew YorkUSA
  4. 4.Unit of Macular Diseases, Department of OphthalmologyUniversity and Polytechnic Hospital La FeValenciaSpain

Personalised recommendations